Avaliação do risco de quedas entre pessoas com doença de Parkinson

Silva, Franciny da; Alvarez, Angela Maria; Nunes, Simony Fabíola Lopes; Silva, Maria Eduarda Massari; Santos, Silvia Maria Azevedo Dos.
Esc. Anna Nery Rev. Enferm ; 26: e20210131, 2022. tab
Artículo en Portugués | LILACS, BDENF - Enfermería | ID: biblio-1360443

Documentos relacionados

  1. Efficacy of pramipexole on quality of life in patients with Parkinson's disease: a systematic review and meta-analysis.
  2. Pramipexole inhibits astrocytic NLRP3 inflammasome activation via Drd3-dependent autophagy in a mouse model of Parkinson's disease.
  3. 15-Year Subthalamic Deep Brain Stimulation outcome in a Parkinson's disease patient with Parkin gene mutation: a case report.
  4. Restless legs syndrome in DNAJC12 deficiency.
  5. P2B001 (Extended Release Pramipexole and Rasagiline): A New Treatment Option in Development for Parkinson's Disease.
  6. Augmentation in patients with restless legs syndrome receiving pramipexole therapy: a retrospective study in a single center from China.
  7. Efficacy and safety of combination therapy with pramipexole and levodopa vs levodopa monotherapy in patients with Parkinson disease: A systematic review and meta-analysis.
  8. PTPRD as a candidate druggable target for therapies for restless legs syndrome?
  9. Dopamine agonist serum concentrations and impulse control disorders in Parkinson's disease.
  10. Screening for impulse control disorders in Parkinson's disease and dopamine agonist use: a study of pharmacokinetic and psychological risk factors.